New and developing therapies for celiac disease

Therapeutic Advances in Gastroenterology

Volumn 2, Issue 5, 2009, Pages 303-309

  Tennyson, Christina A ^a   Lewis, Suzanne K ^a   Green, Peter H R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Celiac disease; Gliadin; Gluten; Prolyl endopeptidases; Therapy

Indexed keywords

GLUTEN; POLYMER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

CELIAC DISEASE; CYTOKINE PRODUCTION; DIET THERAPY; GLUTEN FREE DIET; HUMAN; INTESTINE MUCOSA PERMEABILITY; PRIORITY JOURNAL; REVIEW;

EID: 77953469145     PISSN: 1756283X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756283X09342759     Document Type: Review

References (60)

1. Abdulkarim, A.S., Burgart, L.J., See, J. and Murray, J.A. (2002) Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 97 (8): 2016-2021.
2. Akbari, M.R., Mohammadkhani, A., Fakheri, H., Javad Zahedi, M., Shahbazkhani, B., Nouraie, M. et al. (2006) Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests. Eur J Gastroenterol Hepatol 18 (11): 1181-1186.
3. Bardella, M.T., Molteni, N., Prampolini, L., Giunta, A.M., Baldassarri, A.R., Morganti, D. et al. (1994) Need for follow up in coeliac disease. Arch Dis Child 70 (3): 211-213.
4. Bethune, M.T., Borda, J.T., Ribka, E., Liu, M.X., Phillippi-Falkenstein, K., Jandacek, R.J. et al. (2008) A non-human primate model for gluten sensitivity. PloS ONE 3 (2): e1614.
5. Bethune, M.T., Siegel, M., Howles-Banerji, S. and Khosla, C. (2009) Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides. J Pharmacol Exp Ther 329 (2): 657-668.
6. Bitar, J.G., Salem, A.A. and Nasr, A.T. ( 1970) Celiac disease from the Middle East (report on ten cases seen at the American University of Beirut Hospital). J Med Liban 23 (5): 423-444.
7. Brar, P., Kwon, G.Y., Holleran, S., Bai, D., Tall, A.R. and Ramakrishnan, R. ( 2006a) Change in lipid profile in celiac disease: beneficial effect of gluten-free diet. Am J Med 119 (9): 786-790.
8. Brar, P., Lee, A.R., Lewis, S.K., Bhagat, G., Green, P.H. et al. (2006 b) Celiac disease in African-Americans. Dig Dis Sci 51 (5): 1012-1015.
9. Butterworth, J.R., Banfield, L.M., Iqbal, T.H. and Cooper, B.T. ( 2004) Factors relating to compliance with a gluten-free diet in patients with coeliac disease: comparison of white Caucasian and South Asian patients. Clin Nutr 23 (5): 1127-1134.
10. Casellas, F., Rodrigo, L., Vivancos, J.L., Riestra, S., Pantiga, C., Baudet, J.S. et al. (2008) Factors that impact health-related quality of life in adults with celiac disease: A multicenter study. World J Gastroenterol 14 (1): 46-52.
11. Ciccocioppo, R., Finamore, A., Ara, C., Di Sabatino, A., Mengheri, E. and Corazza, G.R. ( 2006) Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease. Am J Clin Pathol 125 (4): 502-511.
12. Cosnes, J., Cellier, C., Viola, S., Colombel, J.F., Michaud, L., Sarles, J. et al. (2008) Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 6 (7): 753-758.
13. de Angelis, M., Rizzello, C.G., Fasano, A., Clemente, M.G., de Simone, C., Silano, M. et al. (2006) VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue. Biochim Biophys Acta 1762 (1): 80-93.
14. Dickey, W., Ward, M., Whittle, C.R., Kelly, M.T., Pentieva, K., Horigan, G. et al. (2008) Homocysteine and related B-vitamin status in coeliac disease: Effects of gluten exclusion and histological recovery. Scand J Gastroenterol 43 (6): 682-688.
15. Dissanayake, A.S., Truelove, S.C. and Whitehead, R. ( 1974) Jejunal mucosal recovery in coeliac disease in relation to the degree of adherence to a gluten-free diet. Q J Med 43 (170): 161-185.
16. Fabiani, E., Taccari, L.M., Ratsch, I.M., Di Giuseppe, S., Coppa, G.V. and Catassi, C. ( 2000) Compliance with gluten-free diet in adolescents with screening-detected celiac disease: a 5-year follow-up study. J Pediatr 136 (6): 841-843.
17. Fasano, A., Berti, I., Gerarduzzi, T., Not, T., Colletti, R.B., Drago, S., Elitsur, Y. et al. (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163 (3): 286-292.
18. Fasano, A. and Catassi, C. ( 2001) Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120 (3): 636-651.
19. Fasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, A. et al. (2000) Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355 (9214): 1518-1519.
20. Gass, J., Bethune, M.T., Siegel, M., Spencer, A. and Khosla, C. ( 2007) Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology 133 (2): 472-480.
21. Green, P.H. ( 2007) Where are all those patients with Celiac disease? Am J Gastroenterol 102 (7): 1461-1463.
22. Green, P.H. and Cellier, C. ( 2007) Celiac disease. N Engl J Med 357 (17): 1731-1743.
23. Green, P.H. and Jabri, B. ( 2003) Coeliac disease. Lancet 362 (9381): 383-391.
24. Hallert, C., Grant, C., Grehn, S., Granno, C., Hulten, S., Midhagen, G. et al. (2002) Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years. Aliment Pharmacol Ther 16 (7): 1333-1339.
25. Hausch, F., Shan, L., Santiago, N.A., Gray, G.M. and Khosla, C. ( 2002) Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol 283 (4): G996-G1003.
26. Holmes, G.K., Prior, P., Lane, M.R., Pope, D. and Allan, R.N. ( 1989) Malignancy in coeliac disease - effect of a gluten free diet. Gut 30 (3): 333-338.
27. Kim, C.Y., Quarsten, H., Bergseng, E., Khosla, C. and Sollid, L.M. ( 2004) Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA 101 (12): 4175-4179.
28. Kumar, P.J., Walker-Smith, J., Milla, P., Harris, G., Colyer, J. and Halliday, R. ( 1988) The teenage coeliac: follow up study of 102 patients. Arch Dis Child 63 (8): 916-920.
29. Lammers, K.M., Lu, R., Brownley, J., Lu, B., Gerard, C., Thomas, K. et al. (2008) Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135 (1): 194-204.
30. Lee, A. and Newman, J.M. ( 2003) Celiac diet: Its impact on quality of life. J Am Diet Assoc 103 (11): 1533-1535.
31. Lee, A.R., Ng, D.L., Zivin, J. and Green, P.H. ( 2007) Economic burden of a gluten-free diet. J Hum Nutr Diet 20 (5): 423-430.
32. Lee, S.K., Lo, W., Memeo, L., Rotterdam, H. and Green, P.H. ( 2003) Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc 57 (2): 187-191.
33. Leffler, D.A., Edwards-George, J., Dennis, M., Schuppan, D., Cook, F., Franko, D.L. et al. (2008) Factors that influence adherence to a gluten-free diet in adults. Dig Dis Sci 53 (6): 1573-1581.
34. Lindfors, K., Blomqvist, T., Juuti-Uusitalo, K., Stenman, S., Venalainen, J., Maki, M. et al. (2008) Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol 152 (3): 552-558.
35. Matysiak-Budnik, T., Moura, I.C., Arcos-Fajardo, M., Le Breton, C., Menard, S., Candalh, C. et al. (2008) Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 205 (1): 143-154.
36. Meyer, D., Stavropolous, S., Diamond, B., Shane, E. and Green, P.H. ( 2001) Osteoporosis in a north american adult population with celiac disease. Am J Gastroenterol 96 (1): 112-119.
37. Molberg, O., McAdam, S.N., Korner, R., Quarsten, H., Kristiansen, C., Madsen, L. et al. (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4 (6): 713-717.
38. Murray, J.A., Watson, T., Clearman, B. and Mitros, F. ( 2004) Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr 79 (4): 669-673.
39. Mustalahti, K., Lohiniemi, S., Collin, P., Vuolteenaho, N., Laippala, P. and Maki, M. ( 2002) Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract 5 (3): 105-113.
40. Nelson, M., Mendoza, N. and McGough, N. ( 2007) A survey of provision of dietetic services for coeliac disease in the UK. J Hum Nutr Diet 20 (5): 403-411.
41. O'Mahony, S., Howdle, P.D. and Losowsky, M.S. ( 1996) Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 10 (5): 671-680.
42. Paterson, B.M., Lammers, K.M., Arrieta, M.C., Fasano, A. and Meddings, J.B. ( 2007) The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Aliment Pharmacol Ther 26 (5): 757-766.
43. Pinier, M., Verdu, E.F., Nasser-Eddine, M., David, C.S., Vezina, A., Rivard, N. et al. (2008) Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology 136 (1): 288-298.
44. Piper, J.L., Gray, G.M. and Khosla, C. ( 2004) Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo. J Pharmacol Exp Ther 311: 213-219.
45. Qiao, S.W., Bergseng, E., Molberg, O., Xia, J., Fleckenstein, B., Khosla, C. et al. (2004) Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. J Immunol 173 (3): 1757-1762.
46. Ratsch, I.M. and Catassi, C. ( 2001) Coeliac disease: a potentially treatable health problem of Saharawi refugee children. Bull World Health Organ 79 (6): 541-545.
47. Schumann, M., Richter, J.F., Wedell, I., Moos, V., Zimmermann-Kordmann, M., Schneider, T. et al. (2008) Mechanisms of epithelial translocation of the alpha-2-gliadin-33mer in celiac sprue. Gut 57 (6): 747-754.
48. Selby, W.S., Painter, D., Collins, A., Faulkner-Hogg, K.B. and Loblay, R.H. ( 1999) Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten. Scand J Gastroenterol 34 (9): 909-914.
49. Shan, L., Molberg, O., Parrot, I., Hausch, F., Filiz, F., Gray, G.M. et al. (2002) Structural basis for gluten intolerance in celiac sprue. Science 297 (5590): 2275-2279.
50. Siegel, M., Bethune, M.T., Gass, J., Ehren, J., Xia, J., Johannsen, A. et al. (2006) Rational design of combination enzyme therapy for celiac sprue. Chem Biol 13 (6): 649-658.
51. Sollid, L.M. and Lundin, K.E.A. (2009) Diagnosis and treatment of celiac disease. Mucosal Immunol 2 (1): 3-7.
52. Sood, A., Midha, V., Sood, N., Avasthi, G. and Sehgal, A. ( 2006) Prevalence of celiac disease among school children in Punjab, North India. J Gastroenterol Hepatol 21 (10): 1622-1625.
53. Sood, A., Midha, V., Sood, N., Kaushal, V., Puri, H. et al. (2001) Increasing incidence of celiac disease in India. Am J Gastroenterol 96 (9): 2804-2805.
54. Stepniak, D., Spaenij-Dekking, L., Mitea, C., Moester, M., de Ru, A., Baak-Pablo, R. et al. (2006) Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Am J Physiol Gastrointest Liver Physiol 291 (4): G621-G629.
55. Stevens, L. and Rashid, M. ( 2008) Gluten-free and regular foods: a cost comparison. Can J Diet Pract Res 69: 147-150.
56. Vahedi, K., Mascart, F., Mary, J.Y., Laberenne, J.E., Bouhnik, Y., Morin, M.C. et al. (2003) Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 98 (5): 1079-1087.
57. van de Wal, Y., Kooy, Y., van Veelen, P., Pena, S., Mearin, L., Papadopoulos, G. et al. (1998) Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161 (4): 1585-1588.
58. Ventura, A., Magazzu, G. and Greco, L. ( 1999) Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 117 (2): 297-303.
59. Viljamaa, M., Kaukinen, K., Huhtala, H., Kyronpalo, S., Rasmussen, M., Collin, P. et al. (2005) Coeliac disease, autoimmune diseases and gluten exposure. Scand J Gastroenterol 40 (4): 437-443.
60. Whitaker, J.K., West, J. and Logan, R.F. (2009) Patient perceptions of the burden of coeliac disease and its treatment in the UK. Aliment Pharmacol Ther 29 (10): 1131-1136.